AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast

Analytical and Quantitative Cytology and Histology

Volumn 22, Issue 3, 2000, Pages 206-212

  Guski, Hans ^a,c   Hufnagl, Peter ^a   Kaufmann, Olaf ^d   Krause, Matthias ^a,b   Winzer, Klaus Jürgen ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Experimental Surgery and Regenerative Medicine   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NONE

Author keywords

Breast neoplasms; Computer assisted; Ductal carcinoma in situ; Hyperplasia; Image analysis; Nucleolus organizer region; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CHROMOSOME NOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SILVER STAINING;

BIOPSY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARRIER PROTEINS; CELL NUCLEUS; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KI-67 ANTIGEN; NEOPLASM PROTEINS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SILVER STAINING; TUMOR MARKERS, BIOLOGICAL;

EID: 0034124823     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Aubele M, Auer G, Jütting M: Prognostische Wertigkeit von AgNORs beim Mammakarzinom. Zentralbl Pathol 1994;140: 55-60
2. Bässler R, Schneider B, Scheidt E: Histopathologie der Mamma im Spiegel konsiliarischer Untersuchungen: I. Eine Analyse von 1339 Fällen des Mamma-Registers am Pathologischen Institut Fulda. Pathologe 1989;10:135-141
3. Behring F: Morphometrische Untersuchungen zur prognostischen Relevanz der Nukleolus-organisierenden Regionen (AgNORs) beim invasiven duktalen Mammakarzinom unter besonderer Berücksichtigung der Färbemethodik. Dissertation, Dresden-Universität, Medizinische Fakultät, 1996
4. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ: Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Hum Pathol 1993;24: 16-23
5. Bellotti M, Elsner B, Kahn A, Bezodnick L, Pisilli L, Greco P: Morphometric determination of AgNORs in breast carcinoma: Correlation with flow cytometry and proliferating cell nuclear antigen. Analyt Quant Cytol Histol 1997;19:139-144
6. Böcker W, Stegner H-E: Präkanzerosen der weiblichen Brustdrüse. Int Akad Pathol 1996;47:1-50
7. Connolly JL, Fechner RE, Kempson RL, Livolsi VA, Page DL, Patchefsky AA, Silverberg SG: Recommendations for the reporting of breast carcinoma. Am J Clin Pathol 1995;104: 614-617
8. Eskelinen MJ, Lipponen PK, Collan Y, Syrjänen KJ: The role of nucleolar organiser regions as prognostic factors in breast cancer. Eur J Cancer 1991;27:989-992
9. Fechner RE: One century of mammary carcinoma in situ: What have we learned? Am J Clin Pathol 1993;100:654-661
10. Friedrich K, Sturm U, Dimmer U, Flössel C: Darstellung und mögliche prognostische Bedeutung der Nukleolus-organisierenden Regionen (NOR), des Mikrotubuli-assoziierten Proteins 1A/1B (MAP) sowie der Intermediärfilamente Vimentin und Cytokeratin 19 bei invasiven duktalen Mammakarzinomen. Zentralbl Pathol 1994;140:61-71
11. Gimenez-Mas JA, Gallego-Calvo P, Sanz-Moncasi P, Rios-Mitchell J, Valero I, Sanz-Anquela M, Burriel J, Bavai A: AgNOR evaluation by image processing methods: Staining modifications and results in 126 invasive ductal breast carcinomas. Analyt Quant Cytol Histol 1996;18:9-18
12. Gupta GR, Datta BN, Bose SM, Joshi K: Correlation of the growth fraction, nucleolar organizer region counts and epidermal growth factor receptor with histomorphological prognostic criteria in breast cancer. Ind J Pathol Microbiol 1997;40:3-10
13. Guski H, Hufnagl P, Winzer K-J: Nucleolus organizer regions in diagnostic tumor pathology. In Pathology of the Visceral Regulation and Tissue Growths. Edited by VA Frolov, EA Demurov, GM Drogova, GA Drozdova. Moscow, Isdatelstvo PAIMS, 1995, pp 29-32
14. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, Zafrani B: Ductal carcinoma in situ: A proposal for a new classification. Semin Diagn Pathol 1994;11:167-180
15. Holzner JH: Histologie, Grenzformen des Normalen und pathologische Proliferationsmuster der Mamma. Verh Dtsch Ges Pathol 1985;69:26-50
16. Hufnagl P, Beil M, Wenzelides K, Martin H: Die Vermessung der Anzahl, Größe und Lage der AgNORs in histologischen Schnitten von Astrozytomen und Harnblasenkarzinomen. Zentralbl Pathol 1991;137:493-497
17. Hufnagl P, Guski H, Schulz H-J: Measuring of AgNORs using image analysis. Zentralbl Pathol 1994;140:31-35
18. Hufnagl P, Wenzelides K: Methoden der Charakterisierung histologischer Schnittpräparate auf der Basis des AMBA/ R-Systems. Gegenbaurs Morphol Jahrb 1989;138:33-38
19. Hufnagl U: Zur Bedeutung der quantitativen Erfassung von Anzahl, Größe und räumlicher Verteilung von AgNORs für die Diagnostik maligner Geschwülste: Eine vergleichende Untersuchung. Dissertation, Humboldt-Universität, Medizinische Fakultät, 1994
20. Kesari AL, Chellam VG, Nair PP, Madhavan J, Nair P, Nair MK, Pillai MR: Tumor proliferative fraction in infiltrating duct carcinoma. Gen Diagn Pathol 1997;143:219-224
21. Kumar A, Kushwaha AK, Kumar M, Gupta S: Argyrophilic nucleolar organizer regions: Their value and correlation with clinical prognostic factors in breast carcinoma. J Surg Oncol 1997;65:201-204
22. Krause M: Zur Bedeutung der Nukleolus-organisierenden Regionen (NORs) bei Präkanzerosen und Karzinomen der Brustdrüse unter besonderer Berücksichtigung frühinvasiver Tumoren. Dissertation, Humboldt-Universität, Medizinische Fakultät, 1995
23. Lagios MD: Duct carcinoma in situ, pathology and treatment. Surg Clin North Am 1990;70:853-871
24. Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-624
25. Lagios MD, Westdahl PR, Margolin FR, Rose MR: Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-1314
26. Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS: Ductal carcinoma in situ of the breast: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and C-erb-2 protein. Cancer 1995;75:2123-2131
27. Lennington WJ, Jensen RA, Dalton LW, Page DL: Ductal carcinoma in situ of the breast: Heterogeneity of individual lesions. Cancer 1994;73:118-124
28. Lipponen P, Aaltomaa S, Syrjänen K: Morphometric quantitation of nucleolar organizer region proteins in breast carcinoma. Analyt Quant Cytol Histol 1993;15:311-316
29. Martin H: Die Bedeutung der AgNOR: Analyse bei malignen Tumoren. Zentralbl Pathol 1994;140:15-22
30. Martin H, Hufnagl P, Beil M, Wenzelides K, Gottschalk J, Rahn W: Nucleolar organizer region-associated proteins in cancer cells: Quantitative investigations on gliomas, meningiomas, urinary bladder carcinomas and pleural lesions. Analyt Quant Cytol Histol 1992;14:312-319
31. Mourad WA: Aneuploidy in sclerosing adenosis may predict an increased risk of malignancy: A study using the AgNOR silver stain. Pathology 1997;29:255-259
32. Öfner D, Bier B, Heinrichs S, Berhorn M, Dunser M, Hagemann HA, Langer D, Böcker W, Schmid KW: Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: Correlation to tumor stage and long-term survival. Breast Cancer Res Treat 1996;39:165-176
33. Patchefsky AS, Schwartz GF, Finkelstein SD, Prestipino A, Sohn SE, Singer JS, Feig SA: Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63:731-741
34. Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blarney RW, Ellis IO: Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994;7:257-262
35. Remmele W, Stegner HE: Vorschlag zur einheitlichen Definition eines immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 1987;8:138-140
36. Rüschoff J: Nucleolus Organisierende Regionen (NORs) in der Pathomorphologischen Tumordiagnostik. Stuttgart, Jena, 1992
37. Sacks NPM, Robertson JFR, Ellis IO, Nicholson RI, Crocker J, Blarney RW: Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer. Eur J Surg Oncol 1992;18:98-102
38. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ: Prognostic classification of breast ductal carcinoma in situ. Lancet 1995;345:1154-1157
39. Toikkanen S, Joensuu H: AgNOR counts have no prognostic value in breast cancer. J Pathol 1993;169:251-254